Parallel Advisors »

Crescent Biopharma shares owned by Parallel Advisors

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.8k 264 18.37

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Microsoft Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Victoryshares Free Cash Flow Etf Etf (VFLO)

View all positions for Parallel Advisors

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
Tang Capital Management
Vanguard Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma